GB1177206A - Lung Antiviral Factor - Google Patents
Lung Antiviral FactorInfo
- Publication number
- GB1177206A GB1177206A GB6154/68A GB615468A GB1177206A GB 1177206 A GB1177206 A GB 1177206A GB 6154/68 A GB6154/68 A GB 6154/68A GB 615468 A GB615468 A GB 615468A GB 1177206 A GB1177206 A GB 1177206A
- Authority
- GB
- United Kingdom
- Prior art keywords
- antiviral
- antiviral material
- tissue
- animal lung
- lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,177,206. Antiviral material. CHASPFIZER & CO. Inc. 7 Feb., 1968 [28 Nov., 1967], No. 6154/68. Heading A5B. An antiviral material capable of destroying the infectivity of respiratory viruses is prepared by a process comprising the steps of: (a) incubating with agitation a suspension of substantially blood-free animal lung tissue in a culture medium containing from 2 to 4 mg./ml of a yeast ribonucleic acid at about 37‹C for at least about 48 hours; (b) adjusting the resulting incubated material to a pH of from 1 to 2; (c) removing the precipitated proteinaceous material; and (d) readjusting the pH of the remaining filtrate to a pH of from 7 to 7.5 and recovering the anti-viral material e.g. by lyophilization. The animal lung' tissue may be bovine, human, rabbit, mouse, hamster, monkey or guinea pig. The antiviral material may be administered by intranasal or nasopharyngeal drops or by inhalation as delivered by a nebulizer, aerosol or vaporizers in the form of solutions, suspensions, emulsions, powders or dust. Other medicinal agents e.g. analgesics, antibiotics, anaesthetics, decongestants and vaccines may be employed in combination with the antiviral material.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68630767A | 1967-11-28 | 1967-11-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1177206A true GB1177206A (en) | 1970-01-07 |
Family
ID=24755779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB6154/68A Expired GB1177206A (en) | 1967-11-28 | 1968-02-07 | Lung Antiviral Factor |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB1177206A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10363243B2 (en) | 2009-06-26 | 2019-07-30 | Romark Laboratories L.C. | Compounds and methods for treating influenza |
| USRE47786E1 (en) | 2009-05-12 | 2019-12-31 | Romark Laboratories L.C. | Haloalkyl heteroaryl benzamide compounds |
-
1968
- 1968-02-07 GB GB6154/68A patent/GB1177206A/en not_active Expired
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE47786E1 (en) | 2009-05-12 | 2019-12-31 | Romark Laboratories L.C. | Haloalkyl heteroaryl benzamide compounds |
| US10363243B2 (en) | 2009-06-26 | 2019-07-30 | Romark Laboratories L.C. | Compounds and methods for treating influenza |
| US10912768B2 (en) | 2009-06-26 | 2021-02-09 | Romark Laboratories L.C. | Compounds and methods for treating influenza |
| US11850237B2 (en) | 2009-06-26 | 2023-12-26 | Romark Laboratories L.C. | Compounds and methods for treating influenza |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8202584A1 (en) | Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer. | |
| Park et al. | Herpetic keratoconjunctivitis: therapy with synthetic double-stranded RNA | |
| ES2061772T3 (en) | INHALING AEROSOL INCLUDING A RETINOL ESTER AND / OR RETHINIC ACID. | |
| CN104203267A (en) | Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients | |
| Constantine et al. | Rabies virus in nasal mucosa of naturally infected bats | |
| AU2948592A (en) | Artificial nose for a tracheotomy patient | |
| AU5956486A (en) | Liposome inhalation method and system | |
| FI951465A (en) | Pulmonary administration of active fragments of parathyroid hormone | |
| ATE43497T1 (en) | PHARMACEUTICAL FORMULATION WITH CONTROLLED ABSORPTION. | |
| GB1439407A (en) | Method for preventing respiratory mycoplasmosis of livestock | |
| Couch et al. | Aerosol-induced adenoviral illness resembling the naturally occurring illness in military recruits | |
| Deshpande et al. | Receptor-mediated peptide delivery in pulmonary epithelial monolayers | |
| GB1177206A (en) | Lung Antiviral Factor | |
| JPS5817167B2 (en) | Pharmaceutical composition with antiviral action | |
| ES8608581A1 (en) | Synthetic genes for bovine parainfluenza virus | |
| Eagle | Relative Growth-Promoting Activity in Tissue Culture of Go-Factors and the Parent Vitamins | |
| DE3464244D1 (en) | 1- (4'ALKYLSULFONYLPHENYL) -2-AMINO-1,3-PROPANEDIOL N-SUBSTITUTED DERIVATIVES | |
| DE3688617D1 (en) | METHOD FOR ADMINISTERING A SOLID PARTICLE-SHAPED COMPONENT IN AEROSOL PREPARATIONS FOR INHALING THE NICOTINE. | |
| GB1446107A (en) | Production of vaccines | |
| HUP9800520A2 (en) | Gene expression in mammalian cells | |
| FR2423217A2 (en) | Administration of myxomatosis vaccine - by inhalation of aerosol or nasal instillation | |
| Willems et al. | Growth of Sendai virus in organ cultures of mouse tissue | |
| Hashimoto et al. | The Mode of Production of Endotoxin‐Induced Interferon in Rabbit Tissue Cells: I. Development of Priming by Pretreatment with Interferon | |
| Schwab et al. | Reactions of monkeys to experimental respiratory infections. II. Response to streptococcus hemolyticus group c | |
| GB1480690A (en) | Tissue culture media |